Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Bio-Tech Imaging Opens Shreveport Plant
Bio-Tech Imaging (BTI), based in Frederick, Md., has opened a 33,000-sf production plant in Shreveport. The $15 million facility will produce the company’s “Tagger”AIDS-detection kits. Currently the kits are used for private scientific research. BTI is awaiting FDA approval to extend marketing of the kits to hospitals, doctors, and blood banks. BTI hopes to occupy the plant by early 2002.
SEC To Build HQ at Station Place
The U.S. Securities and Exchange Commission has decided that its new 650,000-sf headquarters—called Station Place—will be built adjacent to Union Station and the Thurgood Marshall Building. The architect for the project is New York-based Kevin Roche John Dinkeloo and Associates; it will be developed by Louis Dreyfus Properties, also of New York. December 2003 is the scheduled occupancy date.
University Hospitals of Cleveland Plans New Research Building
University Hospitals of Cleveland is planning a new $110 million, 320,000-gsf Research Institute Building for advanced biomedical research programs, scheduled to open in 2003. Research functions are distributed over eight floors, including two floors below grade dedicated to lab and building support. The ground floor level includes a conferences center; administrative offices are on the second floor. Five floors of generic research labs, lab support, and offices will accommodate 120 researchers on each floor.
Maryland Science/Tech Center Nears Phase I Completion
Maryland Science and Technology Center, a $60 million, 14-building complex, expects to complete Phase I of construction—a total of 120,000 sf of space in one office building and two flex and R&D buildings—by February 2002. The buildings were designed by Robert T. Hoffman. Phase II construction will create four flex and R&D facilities. MEI Properties is the developer of the project at the 466-acre office park.
Charles River Labs Builds Transgenic Facility
Charles River Laboratories International, a provider of contract services and research animals to the biotech and pharmaceutical industries, has a 68,000-sf transgenic facility under construction at their Wilmington headquarters. Completion of the building is anticipated in spring 2002. Demand for the company’s products increased significantly as the mapping of the human genome revealed genetic similarities between mice and humans.